Belumosudil and Rifapentine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Rifapentine
Belumosudil
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Belumosudil (Rezurock) is the medicine treating your graft-versus-host disease. Rifapentine (Priftin) is an antibiotic used for tuberculosis, and it speeds up the liver enzyme that breaks down belumosudil. That means your body clears belumosudil faster, so there's less of it in your blood to do its job.
The concern here isn't a dangerous side effect. It's the opposite: belumosudil may not work as well as it should. The good news is your care team can plan for this by adjusting your belumosudil dose. Please don't change anything on your own, just talk with your doctor or pharmacist so they can manage it.
Interaction: Rifapentine, a strong CYP3A inducer, induces CYP3A-mediated metabolism of belumosudil (a CYP3A substrate), reducing belumosudil exposure and potentially its efficacy.
- Direction: Reduced belumosudil effect (loss of efficacy), not toxicity.
- Magnitude: With rifampin (analogous strong inducer), belumosudil Cmax fell ~59% and AUC ~72%.
- Evidence: Probable; severity major.
- Management: If coadministered, increase belumosudil to 200 mg twice daily per labeling. Monitor GVHD response clinically.
Neither agent's active moiety depends on CYP3A activation, so the induction straightforwardly lowers active drug levels.
What happens
Reduced belumosudil exposure and reduced efficacy of belumosudil
Interaction Deep Dive
When belumosudil (a CYP3A substrate) is given together with a potent CYP3A inducer, belumosudil exposure can fall, potentially lowering the effectiveness of belumosudil. A drug interaction study conducted in healthy subjects showed that giving belumosudil alongside rifAMPin (a strong CYP3A inducer) lowered belumosudil Cmax by 59% and AUC by 72%. Should belumosudil be used concurrently with a strong CYP3A inducer, raise the belumosudil dose to 200 mg twice daily1.
Why it happens (mechanism)
Induction of CYP3A-mediated belumosudil metabolism
How to manage this interaction
What your care team may do:
- Increase your belumosudil dose to 200 mg twice daily while you are also taking rifapentine, as the labeling recommends, so you keep an effective amount of drug in your body.
- Watch your graft-versus-host disease more closely to make sure treatment is still working.
What you should do:
- Keep taking both medicines exactly as prescribed.
- Tell your pharmacist or prescriber that you are on both drugs so they can adjust and individualize your dose.
- Report any worsening of your GVHD symptoms.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In a drug interaction study conducted in healthy subjects, giving belumosudil together with rifAMPin (a strong CYP3A inducer) reduced belumosudil Cmax by 59% and AUC by 72% 1.
Common questions
Can I take Belumosudil and Rifapentine together?
Rifapentine can lower belumosudil levels and make it less effective, but your care team can manage this by raising the belumosudil dose (typically to 200 mg twice daily) and monitoring your response. Don't change doses yourself. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Belumosudil and Rifapentine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Belumosudil and Rifapentine interaction managed?
What your care team may do: Increase your belumosudil dose to 200 mg twice daily while you are also taking rifapentine, as the labeling recommends, so you keep an effective amount of drug in your body. Watch your graft-versus-host disease more closely to make sure treatment is still working. What you should do: Keep taking both medicines exactly as prescribed. Tell your pharmacist or prescriber th… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Belumosudil or Rifapentine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: REZUROCK(R) oral tablets, belumosudil oral tablets. Kadmon Pharmaceuticals LLC (per FDA), Bridgewater, NJ, 2024. DailyMed
Keep reading about Rifapentine
Keep reading about Belumosudil
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist